| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hepoxilin-epoxide hydrolase activity | 8.01e-06 | 2 | 57 | 2 | GO:0047977 | |
| GeneOntologyMolecularFunction | hepoxilin A3 synthase activity | 8.01e-06 | 2 | 57 | 2 | GO:0051120 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RASGRP4 KIAA1755 ARHGAP9 PLEKHG2 AGAP7P C9orf72 AGAP4 AGAP6 RGS12 | 1.24e-05 | 507 | 57 | 9 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RASGRP4 KIAA1755 ARHGAP9 PLEKHG2 AGAP7P C9orf72 AGAP4 AGAP6 RGS12 | 1.24e-05 | 507 | 57 | 9 | GO:0030695 |
| GeneOntologyMolecularFunction | linoleate 13S-lipoxygenase activity | 2.40e-05 | 3 | 57 | 2 | GO:0016165 | |
| GeneOntologyMolecularFunction | arachidonate 15-lipoxygenase activity | 2.40e-05 | 3 | 57 | 2 | GO:0050473 | |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 4.79e-05 | 4 | 57 | 2 | GO:0004052 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 4.85e-05 | 25 | 57 | 3 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 5.47e-05 | 26 | 57 | 3 | GO:0016701 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 4.33e-04 | 11 | 57 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 6.12e-04 | 13 | 57 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 6.12e-04 | 13 | 57 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.19e-03 | 279 | 57 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.95e-03 | 23 | 57 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | NCOR1 RASGRP4 FRY KIAA1755 ARHGAP9 PLEKHG2 AGAP7P C9orf72 AGAP4 AGAP6 RGS12 | 1.98e-03 | 1418 | 57 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | dioxygenase activity | 2.77e-03 | 98 | 57 | 3 | GO:0051213 | |
| GeneOntologyMolecularFunction | poly(A) binding | 3.09e-03 | 29 | 57 | 2 | GO:0008143 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 9.95e-07 | 8 | 55 | 3 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 9.95e-07 | 8 | 55 | 3 | GO:0051122 | |
| GeneOntologyBiologicalProcess | lipoxygenase pathway | 2.92e-06 | 11 | 55 | 3 | GO:0019372 | |
| GeneOntologyBiologicalProcess | lipoxin A4 biosynthetic process | 2.09e-05 | 3 | 55 | 2 | GO:2001303 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 3.06e-05 | 23 | 55 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 4.17e-05 | 4 | 55 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | lipoxin A4 metabolic process | 4.17e-05 | 4 | 55 | 2 | GO:2001302 | |
| GeneOntologyBiologicalProcess | lipoxin biosynthetic process | 4.17e-05 | 4 | 55 | 2 | GO:2001301 | |
| GeneOntologyBiologicalProcess | peroxisome proliferator activated receptor signaling pathway | 5.61e-05 | 28 | 55 | 3 | GO:0035357 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 6.24e-05 | 29 | 55 | 3 | GO:0042759 | |
| GeneOntologyBiologicalProcess | lipoxin metabolic process | 6.95e-05 | 5 | 55 | 2 | GO:2001300 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 1.04e-04 | 6 | 55 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 1.78e-04 | 41 | 55 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone receptor signaling pathway | 1.93e-04 | 8 | 55 | 2 | GO:0002155 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.00e-04 | 202 | 55 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 2.48e-04 | 9 | 55 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | lipid modification | 2.62e-04 | 214 | 55 | 5 | GO:0030258 | |
| GeneOntologyCellularComponent | sperm cytoplasmic droplet | 7.53e-05 | 5 | 58 | 2 | GO:0097598 | |
| Domain | LipOase_mml | 5.07e-07 | 6 | 56 | 3 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 5.07e-07 | 6 | 56 | 3 | PS00711 | |
| Domain | LipOase_C | 5.07e-07 | 6 | 56 | 3 | IPR013819 | |
| Domain | Lipoxygenase | 5.07e-07 | 6 | 56 | 3 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 5.07e-07 | 6 | 56 | 3 | PS51393 | |
| Domain | LIPOXYGENASE_2 | 5.07e-07 | 6 | 56 | 3 | PS00081 | |
| Domain | LipOase | 5.07e-07 | 6 | 56 | 3 | IPR000907 | |
| Domain | LipOase_Fe_BS | 5.07e-07 | 6 | 56 | 3 | IPR020833 | |
| Domain | LipOase_CS | 5.07e-07 | 6 | 56 | 3 | IPR020834 | |
| Domain | LH2 | 2.02e-05 | 18 | 56 | 3 | SM00308 | |
| Domain | PLAT | 3.27e-05 | 21 | 56 | 3 | PS50095 | |
| Domain | - | 3.27e-05 | 21 | 56 | 3 | 2.60.60.20 | |
| Domain | PLAT | 3.27e-05 | 21 | 56 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 3.27e-05 | 21 | 56 | 3 | IPR001024 | |
| Domain | ArfGap | 8.83e-05 | 29 | 56 | 3 | SM00105 | |
| Domain | ArfGap | 8.83e-05 | 29 | 56 | 3 | PF01412 | |
| Domain | ARFGAP | 8.83e-05 | 29 | 56 | 3 | PS50115 | |
| Domain | ArfGAP | 8.83e-05 | 29 | 56 | 3 | IPR001164 | |
| Domain | Ank_3 | 3.91e-04 | 10 | 56 | 2 | PF13606 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 9.04e-04 | 15 | 56 | 2 | IPR003117 | |
| Domain | ANK | 9.20e-04 | 251 | 56 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 9.54e-04 | 253 | 56 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 9.70e-04 | 254 | 56 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 9.70e-04 | 254 | 56 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 1.11e-03 | 262 | 56 | 5 | IPR002110 | |
| Domain | PH | 1.45e-03 | 278 | 56 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 1.47e-03 | 279 | 56 | 5 | PS50003 | |
| Domain | PH_domain | 1.50e-03 | 280 | 56 | 5 | IPR001849 | |
| Domain | PH_dom-like | 1.68e-03 | 426 | 56 | 6 | IPR011993 | |
| Domain | tRNA-bd_arm | 2.34e-03 | 24 | 56 | 2 | IPR010978 | |
| Domain | SAM | 2.34e-03 | 88 | 56 | 3 | SM00454 | |
| Domain | SAM_DOMAIN | 2.91e-03 | 95 | 56 | 3 | PS50105 | |
| Domain | SAM | 3.08e-03 | 97 | 56 | 3 | IPR001660 | |
| Domain | Ank_2 | 3.93e-03 | 215 | 56 | 4 | PF12796 | |
| Domain | - | 3.96e-03 | 106 | 56 | 3 | 1.10.150.50 | |
| Domain | RRM_dom | 4.76e-03 | 227 | 56 | 4 | IPR000504 | |
| Domain | Ank | 4.84e-03 | 228 | 56 | 4 | PF00023 | |
| Domain | PH | 4.91e-03 | 229 | 56 | 4 | PF00169 | |
| Domain | RRM | 4.99e-03 | 230 | 56 | 4 | PS50102 | |
| Domain | SAM/pointed | 5.22e-03 | 117 | 56 | 3 | IPR013761 | |
| Domain | - | 6.13e-03 | 244 | 56 | 4 | 3.30.70.330 | |
| Domain | - | 6.24e-03 | 391 | 56 | 5 | 2.30.29.30 | |
| Domain | - | 6.49e-03 | 248 | 56 | 4 | 1.25.40.20 | |
| Domain | SAM_2 | 7.37e-03 | 43 | 56 | 2 | PF07647 | |
| Domain | Nucleotide-bd_a/b_plait | 7.45e-03 | 258 | 56 | 4 | IPR012677 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 7.35e-07 | 7 | 40 | 3 | M27139 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 7.35e-07 | 7 | 40 | 3 | MM14860 | |
| Pathway | WP_METABOLISM_OF_ALPHALINOLENIC_ACID | 1.17e-04 | 6 | 40 | 2 | M39844 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.79e-04 | 9 | 40 | 2 | M29809 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 5.09e-04 | 12 | 40 | 2 | M48064 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 5.57e-04 | 57 | 40 | 3 | M48332 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.16e-04 | 59 | 40 | 3 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.80e-04 | 61 | 40 | 3 | MM14861 | |
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 25313597 | ||
| Pubmed | 2.24e-07 | 529 | 58 | 9 | 14621295 | ||
| Pubmed | 2.45e-07 | 8 | 58 | 3 | 19713213 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 3.67e-07 | 9 | 58 | 3 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 5.24e-07 | 10 | 58 | 3 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 7.19e-07 | 11 | 58 | 3 | 15381706 | |
| Pubmed | 1.24e-06 | 13 | 58 | 3 | 27713690 | ||
| Pubmed | 1.58e-06 | 14 | 58 | 3 | 22453919 | ||
| Pubmed | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. | 2.73e-06 | 2 | 58 | 2 | 30472260 | |
| Pubmed | Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway. | 2.73e-06 | 2 | 58 | 2 | 19373248 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30792307 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25251155 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15708862 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19095999 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21094135 | ||
| Pubmed | Enhancement role of host 12/15-lipoxygenase in melanoma progression. | 2.73e-06 | 2 | 58 | 2 | 23664097 | |
| Pubmed | Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth. | 2.73e-06 | 2 | 58 | 2 | 18187376 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21220563 | ||
| Pubmed | 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma. | 2.73e-06 | 2 | 58 | 2 | 23528921 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22089472 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 32760397 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25187369 | ||
| Pubmed | 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response. | 2.73e-06 | 2 | 58 | 2 | 22215650 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19787041 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18547056 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18780776 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19469483 | ||
| Pubmed | The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs. | 2.73e-06 | 2 | 58 | 2 | 30237084 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15111312 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17520163 | ||
| Pubmed | Human ALOX12, but not ALOX15, is associated with BMD in white men and women. | 2.73e-06 | 2 | 58 | 2 | 16598376 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15681297 | ||
| Pubmed | Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase. | 2.73e-06 | 2 | 58 | 2 | 20570249 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 32324389 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15821731 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15879104 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 29184033 | ||
| Pubmed | The thyroid axis is regulated by NCoR1 via its actions in the pituitary. | 2.73e-06 | 2 | 58 | 2 | 22878400 | |
| Pubmed | Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. | 2.73e-06 | 2 | 58 | 2 | 10330425 | |
| Pubmed | Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation in human keratinocytes. | 2.73e-06 | 2 | 58 | 2 | 18755188 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 7576099 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17045234 | ||
| Pubmed | The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. | 2.73e-06 | 2 | 58 | 2 | 25708815 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25293588 | ||
| Pubmed | Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase. | 2.73e-06 | 2 | 58 | 2 | 12731864 | |
| Pubmed | The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. | 2.73e-06 | 2 | 58 | 2 | 22267335 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19663136 | ||
| Pubmed | 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. | 2.73e-06 | 2 | 58 | 2 | 19675173 | |
| Pubmed | Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice. | 2.73e-06 | 2 | 58 | 2 | 24300237 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.94e-06 | 536 | 58 | 8 | 15840001 | |
| Pubmed | 3.03e-06 | 538 | 58 | 8 | 10512203 | ||
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 7.61e-06 | 23 | 58 | 3 | 25480914 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22825379 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22832496 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18346986 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22279185 | ||
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 8.19e-06 | 3 | 58 | 2 | 24550004 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18006628 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15328042 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19752233 | ||
| Pubmed | Loss of ASP but not ROPN1 reduces mammalian ciliary motility. | 8.19e-06 | 3 | 58 | 2 | 22021175 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31404087 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22637477 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22275252 | ||
| Pubmed | Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. | 8.19e-06 | 3 | 58 | 2 | 18296557 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16514433 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23070608 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30944221 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30407793 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25549319 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23303679 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 34390859 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12569182 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8944751 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19822654 | ||
| Pubmed | Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. | 8.19e-06 | 3 | 58 | 2 | 23079635 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9804773 | ||
| Pubmed | Oxidative metabolism of a fatty acid amide hydrolase-regulated lipid, arachidonoyltaurine. | 8.19e-06 | 3 | 58 | 2 | 18311922 | |
| Pubmed | Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. | 8.19e-06 | 3 | 58 | 2 | 15576842 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.12e-05 | 853 | 58 | 9 | 28718761 | |
| Pubmed | 1.40e-05 | 87 | 58 | 4 | 33798452 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.43e-05 | 184 | 58 | 5 | 32908313 | |
| Pubmed | Functional characterization of genetic enzyme variations in human lipoxygenases. | 1.64e-05 | 4 | 58 | 2 | 24282679 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9518531 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 1570320 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12122008 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 25698732 | ||
| Pubmed | NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. | 1.64e-05 | 4 | 58 | 2 | 25421714 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8188678 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 20068575 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19819949 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10591629 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19509298 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 15256534 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9849963 | ||
| Pubmed | Dual roles for the phosphatase PPM1D in regulating progesterone receptor function. | 1.64e-05 | 4 | 58 | 2 | 16352595 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11124027 | ||
| Pubmed | A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. | 1.64e-05 | 4 | 58 | 2 | 10339548 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 20592751 | ||
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 1.64e-05 | 4 | 58 | 2 | 20003447 | |
| Cytoband | 17p13.1 | 4.61e-04 | 118 | 58 | 3 | 17p13.1 | |
| Cytoband | 10q11.23 | 8.08e-04 | 33 | 58 | 2 | 10q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 9.76e-04 | 346 | 58 | 4 | chr17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 1.77e-03 | 188 | 58 | 3 | chr10q11 | |
| Cytoband | 1q32 | 1.78e-03 | 49 | 58 | 2 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q15 | 2.31e-03 | 56 | 58 | 2 | chr12q15 | |
| GeneFamily | Arachidonate lipoxygenases | 1.71e-07 | 6 | 38 | 3 | 407 | |
| GeneFamily | ArfGAPs | 4.47e-05 | 33 | 38 | 3 | 395 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.76e-05 | 206 | 38 | 5 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 1.44e-04 | 242 | 38 | 5 | 403 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 5.73e-04 | 17 | 38 | 2 | 1291 | |
| GeneFamily | Sterile alpha motif domain containing | 8.31e-04 | 88 | 38 | 3 | 760 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.28e-06 | 185 | 58 | 5 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.99e-06 | 191 | 58 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-06 | 195 | 58 | 5 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.52e-06 | 195 | 58 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-06 | 195 | 58 | 5 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-06 | 200 | 58 | 5 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-06 | 200 | 58 | 5 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-06 | 200 | 58 | 5 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-06 | 200 | 58 | 5 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 200 | 58 | 5 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.25e-06 | 200 | 58 | 5 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 3.94e-05 | 146 | 58 | 4 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 148 | 58 | 4 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-05 | 156 | 58 | 4 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 163 | 58 | 4 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 165 | 58 | 4 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 165 | 58 | 4 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 165 | 58 | 4 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 167 | 58 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 169 | 58 | 4 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.12e-05 | 170 | 58 | 4 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | d582087a983fe20d811d92f0de0458f3cfd71d2b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 170 | 58 | 4 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | dfbe7ba11b867a4e10fa915f282a2e5cb2f5fb8c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.28e-05 | 171 | 58 | 4 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 171 | 58 | 4 | d0d92eb5152410c3b4dd4a3f1dc3cca0e18a85fd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.45e-05 | 172 | 58 | 4 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 7.62e-05 | 173 | 58 | 4 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-05 | 174 | 58 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 174 | 58 | 4 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 175 | 58 | 4 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 176 | 58 | 4 | 98814f0a67411b2f7b25dc489b2aadb77f45a853 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 8.14e-05 | 176 | 58 | 4 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 178 | 58 | 4 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 8.51e-05 | 178 | 58 | 4 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.69e-05 | 179 | 58 | 4 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.69e-05 | 179 | 58 | 4 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 180 | 58 | 4 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 180 | 58 | 4 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.27e-05 | 182 | 58 | 4 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.27e-05 | 182 | 58 | 4 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.47e-05 | 183 | 58 | 4 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-05 | 183 | 58 | 4 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 9.67e-05 | 184 | 58 | 4 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 188 | 58 | 4 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.05e-04 | 188 | 58 | 4 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 188 | 58 | 4 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 189 | 58 | 4 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.07e-04 | 189 | 58 | 4 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-04 | 189 | 58 | 4 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 58 | 4 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.12e-04 | 191 | 58 | 4 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 1.12e-04 | 191 | 58 | 4 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.12e-04 | 191 | 58 | 4 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.14e-04 | 192 | 58 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 192 | 58 | 4 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.14e-04 | 192 | 58 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 58 | 4 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 192 | 58 | 4 | 905217dcfc843d3469e9e71bd33707863b14cc82 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 193 | 58 | 4 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.16e-04 | 193 | 58 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 193 | 58 | 4 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 193 | 58 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 194 | 58 | 4 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 1.19e-04 | 194 | 58 | 4 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 194 | 58 | 4 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 195 | 58 | 4 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 195 | 58 | 4 | be8db0a22ef8ce24819f790b0bd93670e73af76f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 195 | 58 | 4 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 195 | 58 | 4 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 196 | 58 | 4 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 196 | 58 | 4 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 196 | 58 | 4 | 34bd155e6d848eb53d613997c0e244535de30ba3 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.26e-04 | 197 | 58 | 4 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.26e-04 | 197 | 58 | 4 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 197 | 58 | 4 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.26e-04 | 197 | 58 | 4 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-04 | 197 | 58 | 4 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-04 | 197 | 58 | 4 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-04 | 197 | 58 | 4 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-04 | 197 | 58 | 4 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-04 | 197 | 58 | 4 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 197 | 58 | 4 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.26e-04 | 197 | 58 | 4 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-04 | 197 | 58 | 4 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-04 | 197 | 58 | 4 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| Drug | 5-HEPE | 3.72e-08 | 14 | 58 | 4 | CID000001766 | |
| Drug | AC1L3X17 | 4.61e-07 | 25 | 58 | 4 | CID000123644 | |
| Drug | 12-IODE | 5.45e-07 | 7 | 58 | 3 | CID006450050 | |
| Drug | colneleic acid | 8.71e-07 | 8 | 58 | 3 | CID006441681 | |
| Drug | htyA | 8.71e-07 | 8 | 58 | 3 | CID000152267 | |
| Drug | 14,15-leukotriene A4 | 1.30e-06 | 9 | 58 | 3 | CID006439604 | |
| Drug | octadeca-9,12-dien-1-ol | 1.30e-06 | 9 | 58 | 3 | CID000068168 | |
| Drug | 8,15-diHPETE | 1.30e-06 | 9 | 58 | 3 | CID005283181 | |
| Drug | 13-hydroxylinoleic acid | 1.30e-06 | 9 | 58 | 3 | CID006438633 | |
| Drug | AC1NSXHC | 1.30e-06 | 9 | 58 | 3 | CID005371969 | |
| Drug | U-66,855 | 1.30e-06 | 9 | 58 | 3 | CID000127235 | |
| Drug | ODYA | 1.30e-06 | 9 | 58 | 3 | CID000001931 | |
| Drug | 9-HPODE | 1.86e-06 | 10 | 58 | 3 | CID000001928 | |
| Drug | 1,4-pentadiene | 1.86e-06 | 10 | 58 | 3 | CID000011587 | |
| Drug | acetone phenylhydrazone | 2.55e-06 | 11 | 58 | 3 | CID000066026 | |
| Drug | Ity A | 2.55e-06 | 11 | 58 | 3 | CID000188274 | |
| Drug | nonenal | 3.40e-06 | 12 | 58 | 3 | CID003015503 | |
| Drug | AC1NR1Q2 | 4.41e-06 | 13 | 58 | 3 | CID005283190 | |
| Drug | AC1L1BGZ | 4.41e-06 | 13 | 58 | 3 | CID000001435 | |
| Drug | 9-HETE | 4.41e-06 | 13 | 58 | 3 | CID000001926 | |
| Drug | ICI207968 | 4.41e-06 | 13 | 58 | 3 | CID000129095 | |
| Drug | AC1O4E1A | 4.41e-06 | 13 | 58 | 3 | CID006365736 | |
| Drug | AC1NR1LB | 5.60e-06 | 14 | 58 | 3 | CID005283131 | |
| Drug | oxphaman | 5.60e-06 | 14 | 58 | 3 | CID005464022 | |
| Drug | timegadine | 5.60e-06 | 14 | 58 | 3 | CID000068902 | |
| Drug | 17-HdoHE | 5.60e-06 | 14 | 58 | 3 | CID006439179 | |
| Drug | 8R-HpETE | 6.98e-06 | 15 | 58 | 3 | CID005283170 | |
| Drug | Hex-3-enyl acetate | 6.98e-06 | 15 | 58 | 3 | CID000015574 | |
| Drug | 8(S),15(S)-diHETE | 6.98e-06 | 15 | 58 | 3 | CID000001897 | |
| Drug | 13-HpOTrE | 6.98e-06 | 15 | 58 | 3 | CID005282866 | |
| Drug | AC1NR1M2 | 8.58e-06 | 16 | 58 | 3 | CID005283140 | |
| Drug | 12R-HETrE | 8.58e-06 | 16 | 58 | 3 | CID005283149 | |
| Drug | peroxylinolenic acid | 8.58e-06 | 16 | 58 | 3 | CID006439905 | |
| Drug | hex-3-enal | 8.58e-06 | 16 | 58 | 3 | CID000023234 | |
| Drug | 5,15-diHETE | 1.04e-05 | 17 | 58 | 3 | CID005283158 | |
| Drug | cirsiliol | 1.04e-05 | 17 | 58 | 3 | CID000160237 | |
| Drug | FPL 57231 | 1.25e-05 | 18 | 58 | 3 | CID000122212 | |
| Drug | 3-nonenal | 1.25e-05 | 18 | 58 | 3 | CID005283336 | |
| Drug | BW540C | 1.25e-05 | 18 | 58 | 3 | CID000134372 | |
| Drug | AC1O5PL5 | 1.25e-05 | 18 | 58 | 3 | CID006438380 | |
| Drug | L-651,392 | 1.73e-05 | 20 | 58 | 3 | CID000122182 | |
| Drug | TMK777 | 1.73e-05 | 20 | 58 | 3 | CID006438911 | |
| Drug | AC1L2P35 | 1.73e-05 | 20 | 58 | 3 | CID000125736 | |
| Drug | 13(R)-hydroxy-octadeca-(9Z,11E,15Z)-trienoic acid | 1.91e-05 | 3 | 58 | 2 | CID000643726 | |
| Drug | AC1O5S1P | 2.02e-05 | 21 | 58 | 3 | CID006439617 | |
| Drug | AC1NRAUB | 2.02e-05 | 21 | 58 | 3 | CID005288098 | |
| Drug | 20-carboxyleukotriene B4 | 2.02e-05 | 21 | 58 | 3 | CID000001588 | |
| Drug | BM 13.177 | 2.33e-05 | 22 | 58 | 3 | CID000051550 | |
| Drug | 5,8,11-eicosatrienoic acid | 2.33e-05 | 22 | 58 | 3 | CID000004028 | |
| Drug | CGS 8515 | 2.33e-05 | 22 | 58 | 3 | CID000163944 | |
| Drug | diethylcarbamazine | 2.33e-05 | 22 | 58 | 3 | CID000003052 | |
| Drug | L-656,224 | 2.68e-05 | 23 | 58 | 3 | CID000128132 | |
| Drug | AC1NSYHD | 2.68e-05 | 23 | 58 | 3 | CID005319705 | |
| Drug | octadecadienoic acid | 2.68e-05 | 23 | 58 | 3 | CID005312457 | |
| Drug | 13-hydroperoxylinoleic acid | 3.47e-05 | 25 | 58 | 3 | CID006438144 | |
| Drug | pinolenic acid | 3.47e-05 | 25 | 58 | 3 | CID005312493 | |
| Drug | pentylhydrazine | 3.81e-05 | 4 | 58 | 2 | CID000014246 | |
| Drug | AC1NSP79 | 3.81e-05 | 4 | 58 | 2 | CID005313497 | |
| Drug | T-22083 | 3.81e-05 | 4 | 58 | 2 | CID006439700 | |
| Drug | AC1NR0V5 | 3.81e-05 | 4 | 58 | 2 | CID005282813 | |
| Drug | AC1L3WDO | 3.91e-05 | 26 | 58 | 3 | CID000123344 | |
| Drug | 11-HETE | 3.91e-05 | 26 | 58 | 3 | CID000001406 | |
| Drug | 20-hydroxyleukotriene B4 | 3.91e-05 | 26 | 58 | 3 | CID000001589 | |
| Drug | 8-HETE | 3.91e-05 | 26 | 58 | 3 | CID000001898 | |
| Drug | Bhpp | 4.39e-05 | 27 | 58 | 3 | CID000164136 | |
| Drug | BW A4C | 4.39e-05 | 27 | 58 | 3 | CID006438354 | |
| Drug | SC-41930 | 4.39e-05 | 27 | 58 | 3 | CID000114999 | |
| Drug | AC1L1G9E | 4.91e-05 | 28 | 58 | 3 | CID000003586 | |
| Drug | L-649,923 | 4.91e-05 | 28 | 58 | 3 | CID000119331 | |
| Drug | 13-epi-12-oxo-phytodienoic acid | 5.47e-05 | 29 | 58 | 3 | CID000188366 | |
| Drug | nafazatrom | 5.47e-05 | 29 | 58 | 3 | CID000042923 | |
| Drug | 14-hydroxydocosahexaenoic acid | 6.35e-05 | 5 | 58 | 2 | CID006439735 | |
| Drug | N-(3-phenoxycinnamyl)acetohydroxamic acid | 6.35e-05 | 5 | 58 | 2 | ctd:C056614 | |
| Drug | artonin E | 6.35e-05 | 5 | 58 | 2 | CID005481962 | |
| Drug | AC1L2VAC | 6.35e-05 | 5 | 58 | 2 | CID000129261 | |
| Drug | 12-hydroxyheptadecatrienoic acid | 6.70e-05 | 31 | 58 | 3 | CID000001414 | |
| Drug | (Z)-7-[(1R,2R,3R)-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-methyl-5-oxocyclopentyl]hept-5-enoic acid | 8.11e-05 | 33 | 58 | 3 | CID009548573 | |
| Drug | ICI 198,615 | 8.88e-05 | 34 | 58 | 3 | CID000115219 | |
| Drug | AC1L571W | 9.50e-05 | 6 | 58 | 2 | CID000171201 | |
| Drug | colnelenic acid | 9.50e-05 | 6 | 58 | 2 | CID006441679 | |
| Drug | isamoxole | 9.50e-05 | 6 | 58 | 2 | CID000042118 | |
| Drug | 1-oleoyl-2-DHA-PC | 9.50e-05 | 6 | 58 | 2 | CID006438829 | |
| Drug | CPHU | 9.50e-05 | 6 | 58 | 2 | CID000124471 | |
| Drug | BW A797C | 9.50e-05 | 6 | 58 | 2 | CID006439067 | |
| Drug | AC1MQ2IQ | 9.50e-05 | 6 | 58 | 2 | CID003394960 | |
| Drug | tsuwabukinonol | 1.15e-04 | 37 | 58 | 3 | CID006440419 | |
| Drug | sIL-4R | 1.15e-04 | 37 | 58 | 3 | CID000059757 | |
| Drug | RvD1 | 1.33e-04 | 7 | 58 | 2 | CID016061135 | |
| Drug | lupenone | 1.33e-04 | 7 | 58 | 2 | CID000092158 | |
| Drug | dicranin | 1.33e-04 | 7 | 58 | 2 | CID006441084 | |
| Drug | Bay 08276 | 1.33e-04 | 7 | 58 | 2 | CID000134943 | |
| Drug | 11,14,15-THET | 1.34e-04 | 39 | 58 | 3 | CID006439531 | |
| Drug | tricarbon | 1.34e-04 | 39 | 58 | 3 | CID006432003 | |
| Drug | REV 5901 | 1.34e-04 | 39 | 58 | 3 | CID000005059 | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 5076_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 4658_UP | |
| Drug | indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A | 1.46e-04 | 197 | 58 | 5 | 503_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.49e-04 | 198 | 58 | 5 | 1073_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 2271_UP | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; HL60; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 3109_UP | |
| Disease | cerebral palsy (implicated_via_orthology) | 7.29e-07 | 10 | 55 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | mucositis (biomarker_via_orthology) | 3.40e-05 | 5 | 55 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Nasal Cavity Polyp | 1.50e-04 | 55 | 55 | 3 | EFO_1000391 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.86e-04 | 11 | 55 | 2 | DOID:9206 (is_marker_for) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 4.55e-04 | 80 | 55 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | neutrophil percentage of granulocytes | 8.70e-04 | 228 | 55 | 4 | EFO_0007994 | |
| Disease | basophil count, eosinophil count | 1.07e-03 | 241 | 55 | 4 | EFO_0004842, EFO_0005090 | |
| Disease | colon cancer (biomarker_via_orthology) | 2.42e-03 | 39 | 55 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | psoriasis (is_marker_for) | 3.07e-03 | 44 | 55 | 2 | DOID:8893 (is_marker_for) | |
| Disease | Endometrioma | 3.40e-03 | 161 | 55 | 3 | C0269102 | |
| Disease | Endometriosis | 3.40e-03 | 161 | 55 | 3 | C0014175 | |
| Disease | Crohn Disease | 3.95e-03 | 50 | 55 | 2 | C0010346 | |
| Disease | interferon gamma measurement | 4.10e-03 | 51 | 55 | 2 | EFO_0008165 | |
| Disease | susceptibility to common cold measurement | 4.59e-03 | 54 | 55 | 2 | EFO_0008417 | |
| Disease | Peripheral Nervous System Diseases | 4.59e-03 | 54 | 55 | 2 | C4721453 | |
| Disease | breast cancer (is_marker_for) | 5.01e-03 | 185 | 55 | 3 | DOID:1612 (is_marker_for) | |
| Disease | systemic lupus erythematosus, COVID-19 | 5.27e-03 | 58 | 55 | 2 | MONDO_0007915, MONDO_0100096 | |
| Disease | Malignant neoplasm of prostate | 5.75e-03 | 616 | 55 | 5 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPCFSQPTSNMEPPK | 236 | Q8NAT2 | |
| PPTANTPTPVCKRSM | 211 | Q96P64 | |
| PGRMRPNTSCPVPIK | 491 | Q9BYV9 | |
| SPAIPRIPCAMPETV | 856 | P16157 | |
| VKRLMSGPVPPSACP | 261 | P26378 | |
| PSPVTITPSSMRKIC | 696 | Q9NZJ0 | |
| LSPPTMNLRPPKSCG | 21 | Q9H7B7 | |
| RPACPASMPPTKDNL | 491 | Q5T6C5 | |
| PPTANTPTPVCKRSM | 211 | Q5VW22 | |
| PTCCPRPSPAQKAAM | 576 | Q8IY67 | |
| RCPMSGSPAKPSQVP | 461 | Q8IVH8 | |
| RCFPTPQTAMTPQPA | 16 | Q8NCK7 | |
| KDPSNCGMPLTPPTS | 316 | Q71F56 | |
| PKPMPCPSRNTSSPE | 451 | Q5JYT7 | |
| PSSMRQPPPQTKGTT | 606 | Q9BYJ1 | |
| PPPQSTKPSFSAMRR | 1206 | Q8ND23 | |
| PLDMPCTTIPSAPQA | 316 | P29323 | |
| PMDKCITTPSPPTTT | 1391 | Q02817 | |
| VPCPVMDPPSTASSK | 656 | Q8TDF6 | |
| NAPCTMRLPPPTTKD | 556 | P16050 | |
| IACKSPPPESMDTPT | 2101 | P46013 | |
| TCVMTPSPCSTPPVK | 406 | O15297 | |
| NAPCTMRMPPPTTKE | 556 | P18054 | |
| TSQPPRPSCASMVRP | 436 | Q4VXU2 | |
| GRTPTCSRLAPPPMS | 826 | P28290 | |
| TPKTMPRAVGSPLCV | 526 | Q9NYZ3 | |
| PDVSSPTRLPQPCSM | 281 | Q9UHB4 | |
| RSGSPCHQKPMPSLP | 311 | O60308 | |
| DSIPVSNPSCPMIPL | 401 | P14384 | |
| MSSPPSSPQKCPSPI | 201 | Q9Y2H6 | |
| PPTANTPTPVCKRSM | 211 | Q5VUJ5 | |
| TITETKQPQPLPMPC | 1601 | Q5TBA9 | |
| CTPVPVTMTATPPLP | 416 | Q5VT52 | |
| MSTLCPPPSPAVAKT | 1 | Q96LT7 | |
| CETSPPPTPRALRMT | 771 | O75334 | |
| RISCMSKPPAPNPTP | 26 | P46734 | |
| MAQTDKPTCIPPELP | 1 | Q9BZX4 | |
| SCMPTMPPIPARSQS | 1371 | O43426 | |
| VQNPPKPVMTTRPTA | 86 | Q8N3X1 | |
| MDPCNTNPTPMTKPT | 781 | Q15788 | |
| RMLSSTPPTPIACAP | 2391 | O75376 | |
| PSAAPTSTCAPRKMP | 21 | A6NMZ2 | |
| PQTPPSCLKTEIMSP | 571 | Q8IY81 | |
| AKRPTTQPPVMPTTK | 636 | A1L4H1 | |
| PAMSPAVSQPCTPRA | 1306 | P42695 | |
| PSIICMPKQQPSRQP | 171 | Q9NZN8 | |
| MKQPPATTPPFKTHC | 296 | Q63HN8 | |
| PSLKMSSCVPRPPSH | 311 | Q9UN79 | |
| SINCGTLPPPMSKIP | 566 | O14924 | |
| MAQTDKPTCIPPELP | 1 | Q9HAT0 | |
| MPPEALPTCFKPQAT | 956 | O95271 | |
| QASSEQPPPLPRKMC | 126 | Q9BRR9 | |
| QPPPLPRKMCRSVST | 131 | Q9BRR9 | |
| QPPSTTPCPTVMRAE | 556 | Q68DE3 | |
| FPRPGVCPSKMTAQP | 376 | Q9NS98 | |
| MPSIPCLTKIPDVPN | 626 | Q9H7P9 | |
| MPCRTIVPNAPATIP | 871 | Q9Y3S1 | |
| PLPMACPALSESQPK | 756 | Q6P2D8 | |
| SPHSKPNCSTLSPPM | 551 | O75113 |